Ohsu Knight Cancer Institute
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Employees
- -
- Market Cap
- -
Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
- First Posted Date
- 2015-07-21
- Last Posted Date
- 2023-03-21
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 23
- Registration Number
- NCT02503358
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2015-07-21
- Last Posted Date
- 2020-11-23
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 11
- Registration Number
- NCT02504359
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸OHSU Knight Cancer Institute, Portland, Oregon, United States
Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer
- First Posted Date
- 2015-07-17
- Last Posted Date
- 2019-04-03
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 2
- Registration Number
- NCT02501759
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
- Conditions
- Interventions
- First Posted Date
- 2015-04-28
- Last Posted Date
- 2023-09-06
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 20
- Registration Number
- NCT02427841
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
- Conditions
- Interventions
- First Posted Date
- 2015-02-09
- Last Posted Date
- 2022-03-17
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 29
- Registration Number
- NCT02359097
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸OHSU Knight Cancer Institute, Portland, Oregon, United States
CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers
- First Posted Date
- 2015-02-04
- Last Posted Date
- 2020-08-19
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 45
- Registration Number
- NCT02355262
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide
- First Posted Date
- 2014-12-09
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 58
- Registration Number
- NCT02312557
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
Contrast Enhanced MRI of the Prostate
- Conditions
- First Posted Date
- 2014-09-19
- Last Posted Date
- 2020-09-17
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 14
- Registration Number
- NCT02245282
- Locations
- 🇺🇸
Advanced Imaging Research Center, OHSU, Portland, Oregon, United States
Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide
- First Posted Date
- 2014-08-29
- Last Posted Date
- 2020-09-28
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 41
- Registration Number
- NCT02228265
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸UCSF Medical Center-Mount Zion, San Francisco, California, United States
🇺🇸OHSU Knight Cancer Institute, Portland, Oregon, United States
Esophageal Cytology With FISH in Detecting Esophageal Cancer
- Conditions
- Interventions
- First Posted Date
- 2014-03-31
- Last Posted Date
- 2017-05-11
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 50
- Registration Number
- NCT02100189
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States